Regulering av jernbalansen

Tidsskrift for den Norske Laegeforening

Volumn 129, Issue 9, 2009, Pages 858-862

  Borch Iohnsen, Berit ^a   Hagve, Tor Arne ^b,c   Hauge, Anton ^a   Thorstensen, Ketil ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; CATION TRANSPORT PROTEIN; FERRITIN; HEPCIDIN; HFE2 PROTEIN, HUMAN; IRON; IRON BINDING PROTEIN; MEMBRANE PROTEIN; METAL TRANSPORTING PROTEIN 1; TRANSFERRIN RECEPTOR;

BIOSYNTHESIS; BLOOD; GENETICS; HEMOCHROMATOSIS; HUMAN; INTESTINE CELL; IRON OVERLOAD; LIVER; MACROPHAGE; METABOLISM; PHYSIOLOGY; REVIEW;

ANTIMICROBIAL CATIONIC PEPTIDES; CATION TRANSPORT PROTEINS; ENTEROCYTES; FERRITINS; HEMOCHROMATOSIS; HUMANS; IRON; IRON OVERLOAD; IRON-BINDING PROTEINS; LIVER; MACROPHAGES; MEMBRANE PROTEINS; RECEPTORS, TRANSFERRIN;

EID: 65549163006     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.08.0083     Document Type: Article

References (21)

1. Latunde-Dada GO, Van der Westhuizen J, Vulpe CD et al. Molecular and functional roles of duodenal cytochrome B (Dcytb) in iron metabolism. Blood Cells Mol Dis 2002; 29: 356-60.
2. Zoller H, Theurl I, Koch RO et al. Duodenal cytochrome b and hephaestin expression in patients with iron deficiency and hemochromatosis. Gastroenterol 2003; 125: 746-54.
3. Johnson DM, Yamaji S, Tennant J et al. Regulation of divalent metal transporter expression in human intestinal epithelial cells following exposure to non-haem iron. FEBS Lett 2005; 579: 123-9.
4. Latunde-Dada GO, Simpson RJ, McKie AT. Recent advances in mammalian haem transport. Trends Biochem Sci 2006; 31: 182-8.
5. Camachella C. Understanding iron homeostasis genetics through genetic analysis of hemochromatosis and related disorders. Blood 2005; 106: 3710-7.
6. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003; 102: 783-8.
7. Babitt JL, Huang FW, Wrighting DM et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 2006; 38: 531-9.
8. Goswami T, Andrews NC. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 2006; 281: 28494-8.
9. Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol 2007; 69: 69-85.
10. Hentze MW, Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 1996, 93: 8175-82.
11. Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell 2004; 117: 285-97.
12. Wood RJ, Ronnenberg AG. Iron. I: Shils ME, Olson JA, Shike M et al, red. Modern nutrition in health and disease. 10. utg. Baltimore: Lippincott Williams & Wilkins, 2005: 248-70.
13. Feder JN, Gnirke A, Thomas W et al. A novel MHC class I-like gene is mutated in patients with hereditaty haemochromatosis. Nat Genet 1996; 13: 399-408.
14. Åsberg A, Hveem K, Thorstensen K et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001; 36: 1108-15.
15. Pietrangelo A. Hereditary hemochromatosis. Biochim Biophys Acta 2006; 1763: 700-10.
16. Pietrangelo A. Hemochromatosis: an endocrine liver disease. Hepatology 2007; 46: 1291-301.
17. De Domenico I, McVey Ward D, Nemeth E et al. Molecular and clinical correlates in iron overload associated with mutations in ferroportin. Haematologica 2006; 91: 1092-5.
18. Lilleholt K, Hallberg MH, Hagve T-A. Hemoglobinopatier og fremmedartede navn. Tidsskr Nor Lægeforen 2005; 125: 1164-7.
19. Bell H, Berg JP, Undlien DE et al. The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects. Scand J Gastroenterol 2000; 35: 1301-7.
20. Borch-Iohnsen B, Hauge A. Bør jernpreparater reseptbelegges? Tidsskr Nor Lægeforen 2001; 121: 460-2.
21. Hagve T-A, Åsberg A, Ulvik R et al. Hemokromatose - fra underdiagnostisert kuriositet til folkesykdom. Tidsskr Nor Legeforen 2009; 129: 863-6.